Regulatory Approval for Syringes Follows Earlier Pen Launches Alkem noted that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market semaglutide pre-filled syringes
Summary: Most patients notice appetite suppression and early blood glucose improvements within 12 weeks of starting GLP-1 therapy, with measurable weight loss typically appearing after 48 weeks and maximum benefits emerging after several months on the maintenance dose
Skin and collagen talk comes from GHK-Cu (topical and cell-culture data)
Fat Loss Results (After 6 Months) Group 1 (Diet Alone): 14% fat loss Group 2 (Diet + Myo-Inositol): 16.9% fat loss Group 3 (Diet + Myo + D-Chiro Inositol 40:1): 18.9% fat loss Thats 35% more fat loss than diet alone
However, it is the long-term complications that pose significant risks to health, including: Cardiovascular Disease : Diabetes significantly raises the risk of a number of cardiovascular issues, such as atherosclerosis, strokes , heart attacks , and coronary artery disease with angina (chest discomfort)
Ng SW, Norwitz SG, Taylor HS, Norwitz ER
